Table 5 Toxicities of induction chemotherapy and radiotherapy.

From: Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin

Toxicities

Toxicity Grade

P value

0

1

2

3

4

TPF vs GP

The toxicities of IC

Ā Leukopenia

21 (18.6%)

21 (18.6%)

54 (47.8%)

17 (15.0%)

0 (0.0%)

0.189

Ā Thrombocytopenia

78 (69.0%)

24 (21.2%)

7 (6.2%)

3 (2.7%)

1 (0.9%)

0.794

Ā Hemoglobin reduction

63 (55.8%)

48 (42.5%)

2 (1.8%)

0 (0.0%)

0 (0.0%)

0.176

Ā Nausea and vomiting

55 (48.7%)

49 (43.4%)

8 (7.1%)

1 (0.9%)

0 (0.0%)

0.179

Ā Diarrhea

106 (95.6%)

4 (3.5%)

1 (0.9%)

0 (0.0%)

0 (0.0%)

0.203

Ā Hearing loss

110 (97.3%)

3 (1.8%)

1 (0.9%)

0 (0.0%)

0 (0.0%)

0.523

Ā Rash

97 (85.8%)

13 (11.5%)

3 (2.7%)

0 (0.0%)

0 (0.0%)

0.414

Ā Alanine aminotransferase

80 (70.8%)

27 (23.9%)

6 (5.3%)

0 (0.0%)

0 (0.0%)

0.125

Ā Aspartate aminotransferase

89 (78.8%)

18 (15.9%)

6 (5.3%)

0 (0.0%)

0 (0.0%)

0.039

The acute toxicities of radiotherapy

Ā Dermatitis

107 (94.7%)

3 (2.7%)

3 (2.7%)

0 (0.0%)

0 (0.0%)

0.114

Ā Mucositis

84 (74.3%)

23 (20.4)

6 (5.3)

0 (0.0%)

0 (0.0%)

0.740

Ā Dysphagia

99 (87.6%)

13 (11.5%)

1 (0.9%)

0 (0.0%)

0 (0.0%)

0.481

The late toxicities of radiotherapy

Ā Xerostomia

106 (93.8%)

6 (5.3%)

1 (0.9%)

0 (0.0%)

0 (0.0%)

0.773

Ā Neck fibrosis

110 (97.3%)

3 (2.7%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0.592

Ā Trismus

112 (99.1%)

1 (0.9%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0.330

Ā Hearing impairment

103 (91.2%)

6 (5.3%)

4 (3.5%)

0 (0.0%)

0 (0.0%)

0.544

Ā Cerebral injury

112 (99.1%)

1 (0.9%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0.330

Ā Cranial nerve palsy

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

1.000